VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ABCLAbCellera Biologics Inc.
$5.63$1.7B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksABCLPrice History

ABCL logoAbCellera Biologics Inc. (ABCL) Stock Price History

Historical prices from 2020 to 2026

$5.63-0.11  (-1.92%)close Jun 23
Returns
1M
+6.4%
3M
+67.6%
YTD
+64.1%
1Y
+69.1%
3Y
-8.3%
5Y
-23.7%
ATH$71.91Dec 2020-92.2%
ATL$1.89Apr 2025pre-split
Avg Vol (50D)7.4M/ day
52-Week Range$2.75 — $6.79
LowCurrent: $5.63High

Loading 10-year price history...

ABCL Historical Performance

1 YearTotal Return
+69.1%
Price: +69.1%
3 YearsTotal Return
-23.0%
CAGR: -8.3%
Price: -23.0%
5 YearsTotal Return
-74.1%
CAGR: -23.7%
Price: -74.1%
YTD
+64.1%

ABCL Annual Returns

Year-by-year price performance · 2020–2026

Best+12.9%2025
Worst-63.4%2021
Up years2/7
2020-31.7%
2021-63.4%
2022-28.4%
2023-39.8%
2024-48.9%
2025+12.9%
2026+5.2%
2020 annual price return
-31.7%
2021 annual price return
-63.4%
2022 annual price return
-28.4%
2023 annual price return
-39.8%
2024 annual price return
-48.9%
2025 annual price return
+12.9%
2026 annual price return
+5.2%
LessMore
Alpha vs S&P 500
1Y+46.8%
3Y-28.9%
5Y-36.6%

Price returns only.

Download Historical Data

1,388 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ABCL Stock Price Trajectory (2020–2026)

As of June 24, 2026, AbCellera Biologics Inc. (ABCL) trades at $5.63, representing a +69.1% return over the past year. The stock has delivered a -74.1% total return over five years (-23.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $71.91 on December 11, 2020. From this peak, ABCL has corrected -92.2%, currently trading 32% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers TWST (+140.6% 1Y), RXRX (-34.4% 1Y), and SDGR (-26.1% 1Y), ABCL has underperformed the peer group average. Compare ABCL vs TWST →

ABCL Historical Price Data · from 2020

Rows 1–50 of 1,388
Date Open High Low Close Volume Change %
2026-06-235.495.925.475.635.50M-1.92%
2026-06-225.585.875.585.745.45M+3.80%
2026-06-185.635.745.335.536.76M+1.65%
2026-06-175.175.765.175.445.37M+6.88%
2026-06-165.235.295.015.093.63M-3.23%
2026-06-155.495.555.175.263.68M+0.38%
2026-06-125.305.415.135.242.94M-0.57%
2026-06-115.225.325.035.274.03M+3.54%
2026-06-105.205.475.085.093.67M-3.96%
2026-06-095.595.655.025.305.24M-2.21%
2026-06-085.865.945.355.424.75M-3.56%
2026-06-056.226.295.505.628.37M-11.77%
2026-06-045.556.705.556.3710.26M+11.36%
2026-06-036.006.005.615.725.39M-6.69%
2026-06-026.306.446.086.137.74M-5.11%
2026-06-016.156.796.086.469.61M+4.70%
2026-05-295.676.245.536.179.25M+7.68%
2026-05-285.395.925.375.737.61M+5.33%
2026-05-275.245.545.175.446.42M+2.84%
2026-05-265.305.425.105.298.64M+1.73%
2026-05-225.145.435.045.206.43M+1.17%
2026-05-214.455.434.455.1413.86M+12.47%
2026-05-204.104.614.054.578.40M+12.84%
2026-05-194.084.123.944.054.50M-2.64%
2026-05-184.184.253.944.1611.07M+1.71%
2026-05-154.264.284.004.098.80M-7.05%
2026-05-144.764.814.364.407.16M-7.76%
2026-05-134.925.074.674.775.89M-3.64%
2026-05-124.764.984.454.9516.83M-5.71%
2026-05-115.485.635.245.2511.54M+0.19%
2026-05-084.905.254.885.2410.42M+8.71%
2026-05-075.045.244.744.8211.46M-4.37%
2026-05-064.615.054.595.047.52M+8.15%
2026-05-055.045.164.574.6613.25M+1.53%
2026-05-044.444.704.434.597.65M+3.61%
2026-05-014.124.474.034.436.69M+6.75%
2026-04-303.884.163.834.155.94M+8.64%
2026-04-294.094.093.763.8212.11M-8.28%
2026-04-284.034.303.964.1712.81M+0.12%
2026-04-274.134.384.114.1611.88M0.00%
2026-04-244.074.293.974.169.39M+2.72%
2026-04-234.104.293.944.058.14M-0.74%
2026-04-224.054.214.004.085.29M+2.26%
2026-04-213.923.993.833.993.84M+2.05%
2026-04-204.014.033.883.915.19M-2.49%
2026-04-173.924.053.874.014.76M+4.70%
2026-04-163.893.953.783.832.89M-0.78%
2026-04-153.773.903.773.862.97M+2.66%
2026-04-143.783.833.693.763.14M+2.73%
2026-04-133.493.753.483.662.85M+3.39%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ABCL — Frequently Asked Questions

Quick answers to the most common questions about buying ABCL stock.

How has ABCL stock performed recently?

ABCL returned +69.1% over the past year, beating its 5-year annualized CAGR of -23.7%. The stock trades above its 200-day moving average, confirming the uptrend.

What is ABCL's all-time high price?

AbCellera Biologics Inc. reached $71.91 on 2020-12-11. The 52-week high is $6.79. Current 1-year return of +69.1% places the stock closer to historical peaks.

Where can I download ABCL historical price data?

This page provides ABCL daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.

464 data points · sampled from 1,388